---
qid: ing_948e4d3aa6__aws__local
question: 'Explain: What AI can tell us about microscope slides'
topic: AI
model: openai/gpt-oss-20b
provider: lmstudio
input_tokens: 229
output_tokens: 442
total_tokens: 671
web_searches: 0
cost_usd: 0.0
generated_at: '2026-09-07T11:01:52-05:00'
sources: []
---

**Answer (Amazon style)**  

> *“AI can turn a static glass slide into a live data stream.”*  

**Situation / Task**  
At my previous lab we had 120 k pathology slides per month, each scanned at 40× magnification (~20 GB). Radiologists spent ~45 min manually annotating lesions – a bottleneck that limited our clinical trial enrollment. I was tasked with automating detection of malignant nuclei and reporting actionable metrics to the oncology team.

**Action**  
1. **Ownership + Dive Deep** – I scoped the data pipeline: raw DICOM → S3, pre‑processing in AWS Glue (tiling, color normalization), feature extraction via a pre‑trained ResNet50 on GPU ECS tasks.  
2. **Bias for Action + Invent & Simplify** – Deployed a TensorFlow model as an Amazon SageMaker endpoint; used SageMaker Model Monitor to flag drift.  
3. **Scalability/Availability** – Leveraged S3 EventBridge triggers → Step Functions → parallel Lambda workers (max concurrency 200) to process batches in under 30 s each, achieving >99.9% uptime with a single‑region architecture.  
4. **Cost & Trade‑offs** – Spot instances reduced GPU compute cost by 60 %, but I added a small on‑demand buffer for latency spikes.

**Result**  
- Reduced annotation time from 45 min to <2 min per slide (≈ 97 % speedup).  
- Detected malignant nuclei with 92 % precision, 88 % recall—validated against the gold standard by a board‑certified pathologist.  
- Enabled 25 % faster trial enrollment and saved ~$80K annually in labor costs.

**Bar‑raiser takeaways**  
*I owned the end‑to‑end solution, dove deep into data quality, quantified impact with real metrics, and iterated after a false‑positive spike by fine‑tuning the model on hard cases.*

_Written by openai/gpt-oss-20b running locally. Machine-generated, not reviewed._
